DNAGO and Oncologix Tech, Inc. Announce Agreement for Business Combination to Create Publicly Listed Company Focused on Providing clinical genetic testing on all 20,000+ genes encompassing 7,000+ rare genetic diseases at affordable price In conjunction with the business combination agreement, the parties have several local and international commitments for new investments by institutional investors, including Digital Assets and...